“We appreciate the positive step — however small — of opening up a few additional avenues for medical marijuana research,” Aaron Smith, the executive director of the National Cannabis Industry Association said in a statement. “But patients deserve more, and Congress should help them by removing marijuana from the Controlled Substance Act, allowing state programs and medical research to move forward without interference.”

Read more: https://www.yahoo.com/news/dea-made-big-decision-marijuana-174900792.html